Jaringan Laboratorium Medis

Vol. 5 No. 2 (2023): November 2023
Original Articles

Overview of Pulmonary Platelet Index in Patients with Pulmonary Tuberculosis Consuming Anti-Tuberculosis Drugs

PDF
  • S.Y. Didik Widiyanto,
  • Nurul Qomariyah,
  • Eko Naning Sofyanita
S.Y. Didik Widiyanto
Poltekkes Kemenkes Semarang
Nurul Qomariyah
Poltekkes Kemenkes Semarang
Eko Naning Sofyanita
Poltekkes Kemenkes Semarang

Published 2023-12-11

Keywords

  • Tuberculosis,
  • Platelet Index,
  • OAT

Copyright (c) 2023 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Overview of Pulmonary Platelet Index in Patients with Pulmonary Tuberculosis Consuming Anti-Tuberculosis Drugs. (2023). Jaringan Laboratorium Medis, 5(2), 70-75. https://doi.org/10.31983/jlm.v5i2.9646

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Tuberculosis (TB) is a disease caused by the bacterium Mycobacterium tuberculosis which mostly attacks the lungs. Based on several studies, it is stated that tuberculosis sufferers who take OAT for healing experience side effects in the form of lowering the platelet index due to reactions from drugs that lyse platelets. This research is a descriptive study with a cross sectional design. Research was conducted on 30 respondents who consumed OAT. The results of this study obtained results of more than 50% on one of the platelet indices, namely the PWD value, which was obtained with low results with a total of 19 patients (63.3%), while for other indices such as platelet counts there were 21 patients (70%) , MPV in 28 patients (93%) and PCT in 23 patients (77%) had normal results. The conclusion of this study is that platelet index examinations in TB patients tend to be low in MPV and PDW, while they show high results in PLT and PCT examinations.

PDF

Downloads

Download data is not yet available.

References

  1. Afriansya, R., Qomariyah, N., Sugihartono, A., & Sofyanita, E. N. (2022). Profile of Lymposites in New Tuberculosis (TB) Patients in Semarang City. Jurnal Surya Medika (JSM), 8(3), 65-68.
  2. Afriansya, R. R., Sofyanita, E. N., & Suwarsi, S. (2020). Overview of ureum and creatinine levels in hemodialysis patients with chronic kidney disease. Jaringan Laboratorium Medis, 2(1), 6-11.
  3. Aliviameita, A., & Puspitasari. (2019). Buku Ajar Mata Kuliah Hematologi. UMSIDA PRESS.
  4. Astuti, R. P., Sukeksi, A., & Ariyadi, T. (2018). PENGARUH PENGOBATAN TUBERKULOSIS TERHADAP JUMLAH TROMBOSIT PADA PASIEN TUBERKULOSIS PARU 2 DAN 5 BULAN Manuscript.
  5. Fitria, E., & Ramadhan, R. (2017). Karakteristik Penderita Tuberkulosis Paru di Puskesmas Rujukan Mikroskopis Kabupaten Aceh Besar Characteristics Of Tuberculosis Patient In Puskesmas Referral Microscopis Aceh. 13–20.
  6. Irianti, N. T., Kuswandi, Munifyasin, N., & Kusumaningtyas, R. A. (2016). Mengenal Anti-Tuberculosis. Current Bioactive Compounds, 2(1), 105–105. https://doi.org/10.2174/1573407210602010105
  7. Kalma, Rafika, & Bactiar, A. R. (2019). Jurnal Media Analis Kesehatan ISSN : 2621-9557 (Print) ISSN : 2087-1333 (Online). 10(2), 143–151.
  8. Kemenkes. (2017). PERMENKES NO. 67 Tahun 2016 tentang Penanggulangan Tuberkulosis. In Peraturan Menteri Kesehatan Republik Indonesia (pp. 19–24).
  9. Kenedyanti, E., & Sulistyorini, L. (2017). Analisis Mycobacterium Tuberkulosis dan Kondisi Fisik Rumah dengan Kejadian Tuberkulosis Paru. Jurnal Berkala Epidemiologi, 5(2), 152–162. https://doi.org/10.20473/jbe.v5i2.2017.152-162
  10. Lasut, N. M., Rotty, L. W., & Polii, E. B. (2016). Gambaran Kadar Hemoglobin Dan Trombosit Pada Pasien Tuberkulosis Paru Di Rsup. Prof. Dr. Rd Kandou Manado Periode Januari 2014 –DESEMBER 2014. e-CliniC, 4(1).
  11. Rampa, E., Fitrianingsih, & Sinaga, H. (2020). Hail Pemeriksaan Leukosit, Trombosit dan Hemoglobin pada Penderita Tuberkulosis yang Mengonsumsi OAT di RSAL Dr. Soedibjo Sardadi Kota Jayapura. Global Health Science, 5(2), 78–83.
  12. Rizwani, W., Farmasi, M., Farmasi, D., Korespondensi, P., Juang, K., Bireuen, K., Bireuen, K., & Obat, P. (2017). Penggunaan Obat Anti Tuberkulosis Di Puskesmas Kota Juang Kabupaten Bireuen Aceh. Publish By : Jurnal Dunia Farmasi. 1(2), 70–73.
  13. Tolla, N., Perdana, N., Anggeraini, S., & Fidah, N. (2019). Analisis Indeks Trombosit dan Rasio Trombosit Limfosit sebagai Penanda Kerusakan Ginjal pada Penderita Hipertensi Berbagai Derajat Analysis Platelet Indices and Platelet Lymfosit Ratio as A Kidney Damage Marker in Degree of Hipertensi dikenal dengan istil. Medica Arteriana, 1(2), 59–65.
  14. Werdhani, R. A. (2014). Patofisiologi, Diagnosis dan Klasifikasi Tuberkulosis. In Patofisiologi, Diagnosis dan Klasifikasi Tuberkulosis (Vol. 180, pp. 1–10). FKUI. https://doi.org/10.1016/j.chemphyslip.2013.12.004
  15. Yuslita, N., Martin, E., Wulandari, R., Handayani, L., & Oktriyedi, F. (2022). Gambaran Angka Kejadian Tuberculosis Paru di Provinsi Sumatera Selatan Gambaran Angka Kejadian Tuberculosis Paru di Provinsi Sumatera Selatan pada tahun 2007-2018. July. https://doi.org/10.54816/josh.v2i1.503